Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma
Clinical trial NCT04523467 · UNKNOWN
Trial details
- NCT number
- NCT04523467
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2022-12-31
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.